- Previous Close
124.00 - Open
125.00 - Bid 123.50 x --
- Ask 124.50 x --
- Day's Range
124.00 - 125.00 - 52 Week Range
121.50 - 183.00 - Volume
101,032 - Avg. Volume
167,881 - Market Cap (intraday)
14.285B - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
18.48 - EPS (TTM)
6.71 - Earnings Date Mar 13, 2025 - Mar 17, 2025
- Forward Dividend & Yield 7.00 (5.65%)
- Ex-Dividend Date Jul 23, 2024
- 1y Target Est
177.00
TCI Co., Ltd., an original design manufacturer company, engages in the manufacturing, wholesale, and retail of health foods and cosmetics products in Taiwan, Mainland China, the United States, and internationally. The company offers liquid and solid supplements; immunity products; functional probiotics; basic nutrition; detox slimming; body health; sports nutrition supplements product; laundry detergents; hand sanitizers; and functional snacks, which includes, jelly, bars, chocolates, and gummies. It also provides skin care products, such as facial, body sheet, eye, and lip masks; essences; functional sprays; creams; and gels, as well as turnkey services. In addition, the company involved in wholesale of chemical production; research and development of biotechnology and genetics; and selling medical machinery. TCI Co., Ltd. was incorporated in 1980 and is headquartered in Taipei, Taiwan.
www.tci-bio.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 8436.TWO
View MorePerformance Overview: 8436.TWO
Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8436.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8436.TWO
View MoreValuation Measures
Market Cap
14.28B
Enterprise Value
10.86B
Trailing P/E
18.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.95
Price/Book (mrq)
1.82
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
6.61
Financial Highlights
Profitability and Income Statement
Profit Margin
10.54%
Return on Assets (ttm)
3.88%
Return on Equity (ttm)
9.06%
Revenue (ttm)
7.26B
Net Income Avi to Common (ttm)
765.28M
Diluted EPS (ttm)
6.71
Balance Sheet and Cash Flow
Total Cash (mrq)
5.36B
Total Debt/Equity (mrq)
21.08%
Levered Free Cash Flow (ttm)
614.34M